{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T01:18:35Z","timestamp":1765588715769,"version":"3.48.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Carbohydrate Research"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.carres.2025.109688","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:51:36Z","timestamp":1758819096000},"page":"109688","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Silicon-polysaccharide fluorescent nanocomposite for everolimus delivery and theranostic application in clear cell renal cell carcinoma"],"prefix":"10.1016","volume":"558","author":[{"given":"Zhihong","family":"Lv","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyan","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carres.2025.109688_bib1","article-title":"Cuproptosis status affects treatment options about immunotherapy and targeted therapy for patients with kidney renal clear cell carcinoma","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.carres.2025.109688_bib2","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2013.31.15_suppl.e15593","article-title":"A moncentric review of targeted therapy on overall survival in metastatic renal clear cell carcinoma","volume":"31","author":"Tadj","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.carres.2025.109688_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.918647","article-title":"Potential application of pyroptosis in kidney renal clear cell carcinoma immunotherapy and targeted therapy","volume":"13","author":"Qi","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.carres.2025.109688_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115522","article-title":"The potential of targeting cuproptosis in the treatment of kidney renal clear cell carcinoma","volume":"167","author":"Lei","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.carres.2025.109688_bib5","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1200\/jco.2012.30.5_suppl.442","article-title":"What is the benfit of mTOR inhibitors (mTORi) rechallenge in metastatic renal clear cell carcinoma (mRCC) patients (pts) initially treated with TKI?","volume":"30","author":"Maj-Hes","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.carres.2025.109688_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167628","article-title":"High MICAL-L2 promotes cancer progression and drug resistance in renal clear cell carcinoma cells through stabilization of ACTN4 following vimentin expression","volume":"1871","author":"Zhao","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.carres.2025.109688_bib7","doi-asserted-by":"crossref","first-page":"5896","DOI":"10.3390\/cancers13235896","article-title":"Antiangiogenic therapy in clear cell renal carcinoma (CCRC): pharmacological basis and clinical results","volume":"13","author":"Comandone","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.carres.2025.109688_bib8","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2009.27.15_suppl.e16075","article-title":"Phase II study of everolimus (E) with imatinib (IM) in patients with previously-treated renal carcinoma (RCC)","volume":"27","author":"Ryan","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.carres.2025.109688_bib9","article-title":"Recent development of alkali metal complex promoted iso-selective ring-opening polymerization of rac-Lactide","volume":"31","author":"Bhattacharjee","year":"2021","journal-title":"Curr. Opin. Green Sustainable Chem."},{"key":"10.1016\/j.carres.2025.109688_bib10","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1039\/D3CS00343D","article-title":"Click-derived multifunctional metal complexes for diverse applications","volume":"52","author":"Ahmad","year":"2023","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.carres.2025.109688_bib11","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1021\/acs.chemrev.3c00705","article-title":"Polymeric nanoparticles for drug delivery","volume":"124","author":"Beach","year":"2024","journal-title":"Chem. Rev."},{"key":"10.1016\/j.carres.2025.109688_bib12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s43094-020-00167-2","article-title":"Applications of polymer blends in drug delivery","volume":"7","author":"Nyamweya","year":"2021","journal-title":"Futur. J. Pharm. Sci."},{"key":"10.1016\/j.carres.2025.109688_bib13","doi-asserted-by":"crossref","first-page":"8071","DOI":"10.1039\/D0TB01272F","article-title":"Macrophage membrane coated persistent luminescence nanoparticle@MOF-derived mesoporous carbon core\u2013shell nanocomposites for autofluorescence-free imaging-guided chemotherapy","volume":"8","author":"Chen","year":"2020","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.carres.2025.109688_bib14","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1021\/acsami.0c20617","article-title":"One-pot fabrication of hollow porphyrinic MOF nanoparticles with ultrahigh drug loading toward controlled delivery and synergistic cancer therapy","volume":"13","author":"Sun","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.carres.2025.109688_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122112","article-title":"D-mannose functionalized MgAl-LDH\/Fe-MOF nanocomposite as a new intelligent nanoplatform for MTX and DOX co-drug delivery","volume":"625","author":"Pooresmaeil","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.carres.2025.109688_bib16","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1039\/D1TB02518J","article-title":"Advances in antitumor nanomedicine based on functional metal\u2013organic frameworks beyond drug carriers","volume":"10","author":"Wei","year":"2022","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.carres.2025.109688_bib17","article-title":"Preparation and characterization of sodium alginate\/polyvinyl alcohol hydrogel containing drug-loaded chitosan nanoparticles as a drug delivery system","volume":"56","author":"Afshar","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.carres.2025.109688_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.129705","article-title":"Electrospinning\/3D printing drug-loaded antibacterial polycaprolactone nanofiber\/sodium alginate-gelatin hydrogel bilayer scaffold for skin wound repair","volume":"275","author":"Song","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.carres.2025.109688_bib19","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.1021\/acsabm.9b00813","article-title":"Development of microspheres based on thiol-modified sodium alginate for intestinal-targeted drug delivery","volume":"2","author":"Mao","year":"2019","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.carres.2025.109688_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.131969","article-title":"Construction of a pectin\/sodium alginate composite hydrogel delivery system for improving the bioaccessibility of phycocyanin","volume":"269","author":"Li","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.carres.2025.109688_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.126028","article-title":"Fabrication of a three-dimensional printed gelatin\/sodium alginate\/nano-attapulgite composite polymer scaffold loaded with leonurine hydrochloride and its effects on osteogenesis and vascularization","volume":"249","author":"Tan","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.carres.2025.109688_bib22","article-title":"Folic acid conjugated sodium alginate based redox responsive smart functional microgels as a potential targeted anticancer drug carrier","volume":"102","author":"Shee","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.carres.2025.109688_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.matchemphys.2021.125456","article-title":"Novel pH-responsive chitosan\/sodium alginate\/PEG based hydrogels for release of sodium ceftriaxone","volume":"277","author":"Ghauri","year":"2022","journal-title":"Mater. Chem. Phys."},{"key":"10.1016\/j.carres.2025.109688_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.polymertesting.2021.107375","article-title":"pH and reduction dual-responsive feather keratin - sodium alginate nanogels with high drug loading capacity for tumor-targeting DOX delivery","volume":"103","author":"Zhang","year":"2021","journal-title":"Polym. Test."},{"key":"10.1016\/j.carres.2025.109688_bib25","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.3760\/cma.j.issn.0366-6999.20122864","article-title":"Oral everolimus inhibits intimal proliferation in injured carotid artery in rats","volume":"126","author":"Xiao-Fang","year":"2013","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.carres.2025.109688_bib26","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1001\/jamaoncol.2018.2262","article-title":"Everolimus plus exemestane vs everolimus or capecitabine monotherapy for estrogen receptor\u2013positive, HER2-Negative advanced breast cancer: the BOLERO-6 randomized clinical trial","volume":"4","author":"Jerusalem","year":"2018","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.carres.2025.109688_bib27","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1111\/ajt.14897","article-title":"Five-year outcomes in kidney transplant patients randomized to everolimus with cyclosporine withdrawal or low-exposure cyclosporine versus standard therapy","volume":"18","author":"Sommerer","year":"2018","journal-title":"Am. J. Transplant."}],"container-title":["Carbohydrate Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008621525003143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008621525003143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T01:15:12Z","timestamp":1765588512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008621525003143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":27,"alternative-id":["S0008621525003143"],"URL":"https:\/\/doi.org\/10.1016\/j.carres.2025.109688","relation":{},"ISSN":["0008-6215"],"issn-type":[{"type":"print","value":"0008-6215"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Silicon-polysaccharide fluorescent nanocomposite for everolimus delivery and theranostic application in clear cell renal cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Carbohydrate Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carres.2025.109688","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109688"}}